- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GH
Recent news which mentions GH
This Chart Is Why I'm Not Worried About Guardant Health
April 28, 2022
From Motley Fool
From MarketWatch
2 Top Biotech Stocks to Buy in April
April 08, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 07, 2022
From Benzinga
3 CEOs to Invest In
April 01, 2022
From Motley Fool
Why Guardant Health Stock Soared Nearly 10% Higher Today
April 01, 2022
From Motley Fool
Looking for Growth? Check Out These 2 Diagnostics Stocks
March 18, 2022
From Motley Fool
10 Biggest Price Target Changes For Thursday
February 24, 2022
From Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Why Jim Cramer Likes Vertiv And Scotts Miracle-Gro
January 07, 2022
From Benzinga
How Wide Is Fulgent Genetics' Moat?
December 03, 2021
From Motley Fool
68 Biggest Movers From Wednesday
November 26, 2021
From Benzinga
4 Stocks Insiders Are Buying
November 24, 2021
From Benzinga
Detecting Early Cancer Screening Stocks At An Early Stage Is Critical
November 22, 2021
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
From Benzinga
Guardant Health Registers 27% Revenue Growth In Q3, Tops Consensus; Backs FY21 Guidance
November 05, 2021
Tickers
GH
From Benzinga
Guardant Health Inc (GH) Q3 2021 Earnings Call Transcript
November 05, 2021
Tickers
GH
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
This investor crushes his fund’s benchmark with these 10 stocks
October 12, 2021
From MarketWatch
Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg
October 04, 2021
From Benzinga
54 Biggest Movers From Friday
October 04, 2021
From Benzinga
Why Guardant Health Is Down More Than 14% Friday
October 01, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.